Results for: Insulin Pump

Modular Medical, Inc. (MODD) saw its stock price rise after receiving FDA clearance for its MODD1 insulin pump, designed for adults with Type 1 and Type 2 diabetes. The company aims to make diabetes technology more accessible and affordable for underserved communities, with the MODD1 pump expected to be available for sale in early 2025.

Shares of Modular Medical, Inc. (MODD) surged in pre-market trading after the company announced FDA clearance for its MODD1 insulin pump. Other notable movers include Eastside Distilling, YY Group Holding, and Volato Group, while C3.ai, 180 Life Sciences, and Verint Systems experienced declines.